Urban Tapes
The Shkreli Pill
The only pill worth swallowing. Markets, memes, medicine, and mayhem — served straight, no chaser. Watch the video versions on YouTube : https://www.youtube.com/@TheShkreliPill/videos.
Be sure to visit the podcast's website and support the creator: podcasters.spotify.com
Author
Urban Tapes
Category
Podcast website
Latest episode
Oct 4, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Episode 1031: Oracle’s Biggest Risk Isn’t Credit. SanDisk a Valuation Time Bomb, Intel Stock, RARE 06.09.2026 28:36
In this episode, Martin examines Oracle and explains why he believes the company’s biggest risk extends beyond concerns about credit and financing. He also revisits his bearish thesis on SanDisk, arguing that its valuation could leave the stock vulnerable if memory-market expectations weaken. Martin then discusses Intel and analyzes Ultragenyx (RARE), examining their valuations, competitive positi...
Episode 1030: Robinhood: The Short Nobody Sees, Korean Tariff Threat to Chip Stocks, Dell Stock 05.09.2026 26:32
In this episode, Martin lays out his bearish thesis on Robinhood and explains why he believes the market may be overlooking important risks to the company’s valuation and growth expectations. He also discusses the potential impact of Korean tariff developments on semiconductor and memory stocks before analyzing Dell, examining its AI infrastructure exposure, competitive position, valuation, and th...
Episode 1029: Nvidia’s Biggest Advantage Is Under Attack. New Short Positions, Alumis, SLS, MRNA 04.09.2026 20:27
In this episode, Martin discusses why he believes Nvidia’s strongest competitive advantage could face increasing pressure as the AI hardware landscape evolves. He also reveals new short positions and analyzes Alumis, SELLAS Life Sciences (SLS), and Moderna (MRNA), examining their clinical programs, valuations, catalysts, and risks while explaining the reasoning behind his current investment outloo...
Episode 1028: Meta’s Position Is More Fragile Than It Looks, Snowflake vs Broadcom, Ultragenyx Lost Martin Shkreli 04.09.2026 23:33
In this episode, Martin discusses why he believes Meta’s competitive position may be more vulnerable than investors realize, examining the pressures created by rapid changes in artificial intelligence and technology. He also compares Snowflake and Broadcom, analyzing their businesses, valuations, and exposure to the AI boom, before revisiting Ultragenyx and explaining the developments that changed...
Episode 1027: Martin Shkreli Explains Why It's Stupid To Go All In On A Stock 04.09.2026 19:23
In this episode, Martin explains why concentrating an entire portfolio in a single stock can create unnecessary risk, even when an investor has strong conviction in the idea. He discusses position sizing, diversification, probability, expected returns, and the danger of overestimating one's edge, while explaining how disciplined capital allocation can help traders protect against unexpected ou...
Episode 1026: The Short Report Nobody Wants to See. Dell Stock, CAPR, Nvidia, GoPro, Memecoins 03.09.2026 21:20
In this episode, Martin discusses a bearish research report and examines the arguments and market reaction surrounding its conclusions. He also analyzes Dell, Capricor Therapeutics, Nvidia, and GoPro, sharing his perspective on their valuations, catalysts, and investment risks, before revisiting memecoin trading and the volatility, liquidity, and speculation driving crypto markets.
Episode 1025: The GoPro Merger Is Not What It Seems. Covering Salesforce Short, $300k on Memecoins 03.09.2026 24:56
In this episode, Martin examines the proposed GoPro merger and explains why he believes the deal may be more complicated than it initially appears. He also discusses covering his Salesforce short position and reflects on trading roughly $300,000 in memecoins, exploring speculation, liquidity, market psychology, and the risks involved in highly volatile crypto markets.
Episode 1024: Martin Shkreli Has Fun Trading On Pump.fun (This Is Not Financial Advice) 02.09.2026 21:59
In this episode, Martin explores trading on Pump.fun and experiments with the highly speculative world of newly launched crypto tokens. He discusses market psychology, liquidity, momentum, and the dynamics behind rapid price movements, while highlighting the unpredictable nature and substantial risks associated with trading highly speculative cryptocurrency assets.
Martin Shkreli Finance Lesson Part 19 (Archive cut) 30.08.2026 2:00:42
In this archive lesson, Martin continues his discussion of finance, investing, and stock analysis, explaining the concepts he believes are most important for evaluating companies and making investment decisions. He covers valuation, financial statements, risk, expected returns, and portfolio strategy, using practical examples to demonstrate his approach to fundamental analysis and identifying pote...
Episode 1023: Martin Shkreli GOES OFF On A Crypto Bro For Trying To Sue Him 30.08.2026 36:12
In this episode, Martin discusses a dispute with a cryptocurrency investor involving the possibility of legal action and responds to the arguments being made against him. The conversation explores the circumstances behind the disagreement, crypto investing and promotion, financial incentives, and the risks of escalating online disputes into legal conflicts.
Episode 1022: The $93 Billion Question for Nvidia. Meta Has a Big Problem. Google, Microsoft Stock 28.08.2026 25:05
In this episode, Martin examines a major question surrounding Nvidia’s valuation and future growth, focusing on whether AI infrastructure demand can continue supporting current market expectations. He also discusses what he sees as a significant challenge facing Meta and analyzes Google and Microsoft, comparing their AI strategies, competitive positions, valuations, and the factors that could shap...
Episode 1021: Martin Shkreli Releases Supply Chain Data On Godel Terminal 28.08.2026 1:01
In this episode, Martin introduces newly released supply chain data on Godel Terminal and explains how investors can use it to research companies and industries. He discusses how supply chain relationships can provide insight into customers, suppliers, competitive positioning, and potential business trends, while demonstrating how alternative datasets can complement traditional fundamental analysi...
Episode 1020: A Great Nvidia Quarter Could Still Send It Lower 28.08.2026 26:56
In this episode, Martin discusses why even strong quarterly results from Nvidia may not necessarily lead to a higher stock price. He examines the role of elevated expectations, valuation, earnings guidance, AI infrastructure spending, and investor positioning, explaining how a company can deliver impressive financial results while still disappointing a market that has already priced in exceptional...
Episode 1019: Martin "Pharma" Shkreli Responds To A Vaccine Skeptic Larping As An Expert 27.08.2026 8:07
In this episode, Martin responds to a vaccine skeptic and challenges their claims about vaccines, pharmaceutical development, and medical science. Drawing on his background in biotechnology and pharmaceuticals, he examines the evidence behind the arguments, discusses how clinical research and drug development are evaluated, and highlights the importance of distinguishing credible scientific analys...
Episode 1018: I’m Short the Cancer Cure. Huge Biotech Bubble. Moderna, Nvidia, Capricor Stock 27.08.2026 24:41
In this episode, Martin discusses why he believes parts of the biotechnology sector have entered a speculative bubble and explains the reasoning behind a controversial short position in a company developing a potential cancer treatment. He also analyzes Moderna and Capricor Therapeutics, examining their clinical programs, valuations, and investor expectations, before discussing Nvidia and the broa...
Episode 1017: I'm Losing Money on Crypto Pumps. My Trading Prodigy Left Me 27.08.2026 26:56
In this episode, Martin discusses losing money on speculative cryptocurrency trades and reflects on the risks of chasing hype-driven opportunities. He also talks about the departure of his trading intern, sharing lessons from their time working together and examining what makes a talented trader. The discussion covers speculation, trading psychology, risk management, mentorship, and the importance...
Episode 1016: My Genius Intern Quit, I Started Pumping Crypto Scams 26.08.2026 26:06
In this episode, Martin discusses the departure of his trading intern and reflects on the experience of mentoring young traders. He also turns to the speculative side of cryptocurrency markets, discussing crypto promotions, hype-driven trading, and the risks of following questionable investment narratives. The conversation explores market psychology, speculation, incentives, and how traders can di...
Episode 1015: Martin Shkreli Explains Why Smart People Often Are Bad Traders 26.08.2026 9:51
In this episode, Martin discusses why intelligence alone does not necessarily translate into success in financial markets. He explores how overconfidence, overanalysis, emotional decision-making, and an unwillingness to admit mistakes can hurt even highly intelligent traders. Martin also explains the importance of discipline, probability, position sizing, adaptability, and developing a genuine edg...
Episode 1014: How Smart Traders Buy When Everyone Else Panics. Making a Fortune Copying Others 26.08.2026 18:42
In this episode, Martin discusses how disciplined traders can take advantage of market panic by identifying opportunities when fear drives prices away from underlying value. He also explores the idea of learning from and following successful investors, explaining how studying other traders’ positions can uncover opportunities when combined with independent research. The discussion covers contraria...
Episode 1013: AAOI Is Flying Under the Radar, Spruce Biosciences to $500, AMD Could Disappoint 26.08.2026 24:02
In this episode, Martin highlights Applied Optoelectronics (AAOI) as an overlooked opportunity and examines the factors that could drive its future performance. He also lays out an aggressive bullish thesis for Spruce Biosciences, discussing the potential catalysts behind his valuation outlook, and analyzes AMD ahead of key developments, explaining why investor expectations could leave the stock v...
Episode 1012: The Biggest Blind Spot of Short-Term Traders | COMPILATION 25.08.2026 19:47
This compilation brings together Martin’s discussions on the mistakes and overlooked risks that can undermine short-term traders. Across a range of clips, he explores market timing, position sizing, risk management, trading psychology, and the danger of focusing too heavily on immediate price movements. He also explains why understanding valuation, probabilities, and longer-term fundamentals can h...
Episode 1011: Martin Shkreli's Gut Wrenching Prison Stories 25.08.2026 30:11
In this episode, Martin recounts stories from his time in prison and reflects on some of the most difficult and memorable experiences he encountered while incarcerated. He discusses prison culture, relationships with other inmates, daily life behind bars, and the psychological challenges of incarceration, while sharing the lessons and perspectives he took away from the experience.
Episode 1010: Martin Shkreli Shares Wisdom On How To Thrive In Your Corporate And Personal Life 25.08.2026 9:58
In this episode, Martin shares his perspective on building a successful career while navigating the challenges of professional and personal life. He discusses decision-making, ambition, relationships, workplace dynamics, and developing valuable skills, while offering lessons from his own experiences on handling setbacks, pursuing opportunities, and creating a sustainable path toward long-term succ...
Episode 1009: The AI Boom Is About to Turn. CoreWeave’s Growth Has a Catch. Uber to $1 Trillion 24.08.2026 23:31
In this episode, Martin discusses why he believes the current AI investment boom may be approaching an important turning point and examines the risks behind increasingly aggressive infrastructure spending. He analyzes CoreWeave’s rapid growth and explains the potential catch behind its expansion, including capital intensity and the sustainability of AI compute demand. Martin also explores Uber’s l...
Episode 1008: The Next 10x I'm Watching, Apple Growing Too Fast, Applovin LONG, OmniAb, Capricor 23.08.2026 28:29
In this episode, Martin discusses a stock he believes has the potential to deliver outsized long-term returns and explains the thesis behind the opportunity. He also examines Apple’s rapid growth and whether current expectations are sustainable, outlines his bullish view on AppLovin, and analyzes OmniAb and Capricor Therapeutics, focusing on their businesses, valuations, catalysts, and the key ris...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.